Stock BRTL EVOME MEDICAL TECHNOLOGIES INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Evome Medical Technologies Inc.

Equities

BRTL

CA30053H1055

Market Closed - Toronto S.E.
Other stock markets
 15:41:33 2024-06-28 EDT 		5-day change 1st Jan Change
0.095 CAD 0.00% Intraday chart for Evome Medical Technologies Inc. +5.56% -54.76%
06-04 Transcript : Evome Medical Technologies Inc., Q2 2024 Sales/ Trading Statement Call, Jun 04, 2024
05-31 Evome Medical Technologies Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Summary

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Evome Medical Technologies Announces Securities Issuances
AQ
Transcript : Evome Medical Technologies Inc., Q2 2024 Sales/ Trading Statement Call, Jun 04, 2024
Evome Medical Technologies Announces Update Call with CEO Mike Seckler for Tuesday, June 4, 2024; Provides Update on Strong Q2
AQ
Evome Medical Technologies : TECHNOLGIES, INC - Form 6-K
PU
Evome Medical Technologies Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Evome Medical Technologies Provides Biodex Operations Update
MT
Evome Medical Technologies Inc. Receives an Initial Purchase Order from VMS
CI
Evome Medical Technologies Announces Biodex Generated 100% Sales Growth Comparing April 2024 to January 2024, Plans to Shed Remaining Non-Core Units to Pay Off Remaining Acquisition Debt
AQ
Evome Medical Technologies : FOREIGN PRIVATE ISSUER STATUS - Form 6-K
PU
Evome Medical Technologies Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Evome Strengthens Major Creditor Relationship After the Sale of the Simbex Unit to Riddell, LOI Related to Simbex Acquisition Debt is Cancelled
AQ
Canadian Investment Regulatory Organization Trade Resumption - EVMT
AQ
Evome Sells Simbex R&D Business Unit to Riddell for $4.83M in Cash; Improves Balance Sheet, Reduces Biodex Acquisition Debt
AQ
Riddell, Inc. acquired Simbex, LLC from Evome Medical Technologies Inc. for $3.6 million.
CI
Evome Medical Technologies Punctuates Turn Around Plan with Strong Fourth Quarter Resulting in Positive Annual Adjusted EBITDA for Fiscal Year 2023
AQ
Evome Medical Engages ICP Securities Inc. for Automated Market Making Services
AQ
Evome Medical Technologies Bolsters Board of Directors with Appointment of Strategic Senior Healthcare Executives Wayne Anderson and Bill Garbarini, Appoints Kenneth Kashkin, MD, as Chairman
AQ
Evome Medical Technologies Inc. Announces Board Changes
CI
Evome Medical Technologies Executes Non-Binding Letter of Intent to Extend Remaining Simbex Acquisition Debt to June 2025; Increases Sales Targets by 7.5% for Biodex Distribution Contracts; Raises Biodex Product Pricing by 2% for 2024
AQ
Evome Medical Technologies Inc. Announces CFO Changes
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. BRTL Stock
  4. News Evome Medical Technologies Inc.